0001114220-17-000032.txt : 20171006 0001114220-17-000032.hdr.sgml : 20171006 20171006172516 ACCESSION NUMBER: 0001114220-17-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171005 FILED AS OF DATE: 20171006 DATE AS OF CHANGE: 20171006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adams Brian CENTRAL INDEX KEY: 0001636994 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 171128113 MAIL ADDRESS: STREET 1: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-466-3500 MAIL ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 4 1 wf-form4_150732510244312.xml FORM 4 X0306 4 2017-10-05 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001636994 Adams Brian C/O KERYX BIOPHARMACEUTICALS, INC. ONE MARINA PARK DRIVE, 12TH FLOOR BOSTON MA 02210 0 1 0 0 General Counsel and Secretary Common Stock 2017-10-05 4 S 0 630 7.19 D 135420 D Sale of a total of 630 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 1,989 shares of restricted stock on October 4, 2017. Mr. Adams had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock. Includes 77,613 shares of restricted stock. /s/ Brian Adams 2017-10-06